A Daily Network publication
Explore the network
Wealth Advisor Daily
The advisor's edition — practice, portfolio, and the book.
Wednesday, October 7, 2026The Morning Brief →Sign in
ETF PRO AIOctober 7, 2026

BBH VanEck Biotech ETF

Fund tearsheet · data as of the latest session · October 7, 2026

Print / save as PDFPrints clean — the site chrome stays behind.

ONE YEAR OF DAILY CLOSES

0.35%expense ratio
$483Mfund assets
+24.9%return, YTD
+35.7%return, 1 year
−$5Mnet flow, 1 month
−$21Mnet flow, 1 year
21.6%realized volatility, 1y
-10.5%worst drawdown, 1y
Top ten holdings
1AMGN AMGEN15.53%
2GILD GILEAD SCIENCES13.18%
3VRTX VERTEX PHARMACEUTICALS8.17%
4REGN REGENERON PHARMACEUTICALS6.49%
5MRNA MODERNA6.16%
6NTRA NATERA5.46%
7ARGX ARGENX SE4.53%
8IQV IQVIA HOLDINGS4.42%
9RVMD REVOLUTION MEDICINES4.37%
10ILMN ILLUMINA4.15%

PREPARED WITH ETF PRO AI · PRIMARY MARKET DATA · INFORMATIONAL ONLY — NOT AN OFFER, RECOMMENDATION, OR INVESTMENT ADVICE · PAST PERFORMANCE DOES NOT GUARANTEE FUTURE RESULTS

Every weekday · 6:30 a.m. ET

The Morning Brief

The latest from Wealth Advisor Daily, in your inbox every weekday. Free.